Testing effectiveness (Phase 2)Study completedNCT00002879What this trial is testingCladribine in Patients With Mantle Cell LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 51
Not applicableStudy completedNCT00453206What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Wake Forest University Health Sciences 66
Testing effectiveness (Phase 2)Study completedNCT00109993What this trial is testingCampath-1H + FK506 and Methylprednisolone for GVHDWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Case Comprehensive Cancer Center 34
Early research (Phase 1)Study completedNCT00118170What this trial is testingSorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney FunctionWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+42 more National Cancer Institute (NCI) 150
Large-scale testing (Phase 3)UnknownNCT02354313What this trial is testingPhase III, Randomized Trial: Lenalidomide vs Observation After Induction With Rituximab Followed by Cht and ASCT in MCL Adult PatientsWho this might be right forMANTLE CELL LYMPHOMA Fondazione Italiana Linfomi - ETS 300
Testing effectiveness (Phase 2)Study completedNCT01412879What this trial is testingS1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 53
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00387959What this trial is testingChemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center 17
Not applicableStudy completedNCT00248547What this trial is testingAprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantWho this might be right forCancer OHSU Knight Cancer Institute 40
Not applicableStudy completedNCT00416312What this trial is testingIodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Early research (Phase 1)Study completedNCT00244946What this trial is testingCombination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Barbara Ann Karmanos Cancer Institute 15
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT00641381What this trial is testingCarmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated LymphomaWho this might be right forLymphoma City of Hope Medical Center 25
Large-scale testing (Phase 3)Study completedNCT00053053What this trial is testingComparison of Nutritional Supplements in Preventing Weight Loss in Patients With CancerWho this might be right forCachexiaLymphomaLymphoproliferative Disorder+1 more Radiation Therapy Oncology Group 472
Not applicableEnded earlyNCT01076270What this trial is testingPlerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+80 more Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)WithdrawnNCT00004039What this trial is testingCombination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV LymphomaWho this might be right forLymphoma Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)UnknownNCT00008307What this trial is testingCombination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Herbert Irving Comprehensive Cancer Center 52
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Early research (Phase 1)Study completedNCT00352443What this trial is testingS0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific SWOG Cancer Research Network 66
Early research (Phase 1)Study completedNCT00443976What this trial is testingAurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkins LymphomaUnspecified Adult Solid Tumor, Protocol Specific NCIC Clinical Trials Group 35